Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Harrison

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
JMIR Mhealth and Uhealth|November 28, 2025
Evaluation of a Pilot mHealth Intervention to Engage Primary Care Clients at an Urban Clinic Serving Marginalized Populations: Mixed-Methods Cohort StudyLauren Harrison, Christina Fulton, Antonio Marante Changir, et al.
Bone Marrow Transplantation|January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experienceJeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
British Journal of Haematology|May 6, 2017
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group reportSanghoon Lee, Nancy S Day, Rodney R Miles, et al.
British Journal of Haematology|July 29, 2014
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group ReportStanton Goldman, Lynette Smith, Paul Galardy, et al.
British Journal of Haematology|November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Oncotarget|April 22, 2017
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLSanghoon Lee, Wen Luo, Tishi Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipientsPrakash Satwani, Zhezhen Jin, Deirdre Duffy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 20, 2016
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid LeukemiaStacey Zahler, Monica Bhatia, Angela Ricci, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
JMIR Mhealth and Uhealth|November 28, 2025
Evaluation of a Pilot mHealth Intervention to Engage Primary Care Clients at an Urban Clinic Serving Marginalized Populations: Mixed-Methods Cohort StudyLauren Harrison, Christina Fulton, Antonio Marante Changir, et al.
Bone Marrow Transplantation|January 7, 2022
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experienceJeffrey R Andolina, Yi-Cheng Wang, Lingyun Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group studyErin Cooney-Qualter, Mark Krailo, Anne Angiolillo, et al.
British Journal of Haematology|May 6, 2017
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group reportSanghoon Lee, Nancy S Day, Rodney R Miles, et al.
British Journal of Haematology|July 29, 2014
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group ReportStanton Goldman, Lynette Smith, Paul Galardy, et al.
British Journal of Haematology|November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Oncotarget|April 22, 2017
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLSanghoon Lee, Wen Luo, Tishi Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipientsPrakash Satwani, Zhezhen Jin, Deirdre Duffy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 20, 2016
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid LeukemiaStacey Zahler, Monica Bhatia, Angela Ricci, et al.
Pageof 5